Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemoembolization, Therapeutic | 1 | 2022 | 12 | 0.800 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 168 | 0.690 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 278 | 0.650 |
Why?
|
| Reperfusion Injury | 4 | 2010 | 51 | 0.490 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2014 | 6 | 0.480 |
Why?
|
| Brain Diseases | 1 | 2014 | 67 | 0.440 |
Why?
|
| Prostate | 1 | 2010 | 54 | 0.330 |
Why?
|
| Intestines | 1 | 2010 | 156 | 0.320 |
Why?
|
| Ischemia | 1 | 2010 | 192 | 0.300 |
Why?
|
| Lung | 1 | 2010 | 838 | 0.240 |
Why?
|
| Immunity, Innate | 1 | 2010 | 768 | 0.230 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 267 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 2049 | 0.150 |
Why?
|
| Muscle, Skeletal | 3 | 2009 | 677 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 1470 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 556 | 0.130 |
Why?
|
| Dura Mater | 1 | 2014 | 35 | 0.120 |
Why?
|
| Headache | 1 | 2014 | 63 | 0.120 |
Why?
|
| Radiography | 1 | 2014 | 513 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2011 | 17 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2011 | 75 | 0.090 |
Why?
|
| Immunoglobulin M | 2 | 2009 | 112 | 0.080 |
Why?
|
| Lymphocyte Transfusion | 1 | 2009 | 37 | 0.080 |
Why?
|
| Male | 5 | 2014 | 27765 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 571 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 455 | 0.080 |
Why?
|
| Humans | 6 | 2022 | 59799 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 221 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2010 | 459 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 550 | 0.070 |
Why?
|
| Brain | 1 | 2014 | 1492 | 0.070 |
Why?
|
| Rats | 1 | 2010 | 1918 | 0.070 |
Why?
|
| Mast Cells | 1 | 2005 | 41 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 82 | 0.060 |
Why?
|
| Adolescent | 1 | 2014 | 5939 | 0.060 |
Why?
|
| Mice | 4 | 2010 | 10303 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2022 | 127 | 0.050 |
Why?
|
| Animals | 4 | 2010 | 19718 | 0.040 |
Why?
|
| Mass Screening | 1 | 2022 | 658 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 6041 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2006 | 1996 | 0.020 |
Why?
|
| Hindlimb | 1 | 2009 | 44 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 145 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2009 | 76 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 223 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2009 | 193 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2009 | 506 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 452 | 0.020 |
Why?
|
| Peptide Library | 1 | 2006 | 35 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 183 | 0.020 |
Why?
|
| Complement C5a | 1 | 2005 | 5 | 0.020 |
Why?
|
| Complement C4 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 169 | 0.020 |
Why?
|
| Complement C3a | 1 | 2005 | 8 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2005 | 20 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 22 | 0.020 |
Why?
|
| Complement Pathway, Classical | 1 | 2005 | 23 | 0.020 |
Why?
|
| Rhabdomyolysis | 1 | 2005 | 26 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 880 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1134 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 545 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1225 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 3204 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 15879 | 0.010 |
Why?
|